Heart Failure-Inducible Gene Therapy Targeting Protein Phosphatase 1 Prevents Progressive Left Ventricular RemodelingYosuke Miyazaki, Masunori Matsuzaki, Makoto Inui et al.|PLoS ONE|2012Cited by 37
Effects of Oral Tolvaptan Administration in Patients Hospitalized for Chronic Heart Failure with Preserved Ejection Fraction and Chronic Kidney DiseaseKozo Shiraishi, Masunori Matsuzaki, Toshiro Miura et al.|Journal of Cardiac Failure|2011Cited by 0
Heart failure-inducible suppression of protein phosphatase 1β partially prevents cardiac remodeling in experimental pressure overload-induced heart failureKozo Shiraishi, Masafumi Yano, Yasuhiro Ikeda et al.|Institutional Repositories DataBase (IRDB)|2017Cited by 0